News Releases

News Releases

Mar 16, 2020
MYCAPSSA ® PDUFA Date Set for June 26, 2020 ; U.S. Commercial Launch Planned in Q4’20 First Industry Sponsored U.S. Disease State Registry for Acromegaly Began Enrolling Patients NEEDHAM, Mass. , March 16, 2020 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ: CHMA), a clinical stage biopharmaceutical
Jan 10, 2020
MYCAPSSA ® NDA resubmitted to FDA ; PDUFA decision expected mid-2020 MYCAPSSA ® U.S. commercial launch planned for the fourth quarter of 2020 Top-line MYCAPSSA ® MPOWERED Phase 3 results on track for the fourth quarter of 2020 NEEDHAM, Mass. , Jan. 10, 2020 (GLOBE NEWSWIRE) -- Chiasma, Inc.

This section of our website may contain dated or archived information which should not be considered current and may no longer be accurate. For current information, you are encouraged to review our most recent filings with the U.S. Securities and Exchange Commission.

Shareholder Tools